S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
NASDAQ:COWN

Cowen (COWN) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$38.99
$38.99
50-Day Range
$38.84
$39.02
52-Week Range
$21.36
$39.07
Volume
N/A
Average Volume
685,426 shs
Market Capitalization
$1.10 billion
P/E Ratio
17.80
Dividend Yield
1.23%
Price Target
N/A

Cowen MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
-0.74
Upright™ Environmental Score
News Sentiment
0.25mentions of Cowen in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.03 out of 5 stars

Finance Sector

775th out of 848 stocks

Security Brokers & Dealers Industry

25th out of 26 stocks

COWN stock logo

About Cowen Stock (NASDAQ:COWN)

Cowen, Inc. engages in the provision of financial services. It operates through following the segments: Operating Company and Asset Company. The Operating Company segment consists of the Cowen Investment Management, Investment Banking, Markets, and Research divisions. The Asset Company segment consists of the firm's private investments, private real estate investments, and other legacy investment strategies. The firm offers investment banking services, equity and credit research, sales and trading, prime brokerage, global clearing, commission management services, and actively managed alternative investment products. The company was founded in 1918 and is headquartered in New York, NY.

COWN Stock News Headlines

Olivia Cowan odds to win the 2024 The Chevron Championship
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
See More Headlines
Receive COWN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cowen and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/28/2021
Today
4/19/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Finance
Industry
Security brokers & dealers
Sub-Industry
Investment Banking & Brokerage
Current Symbol
NASDAQ:COWN
CUSIP
22362210
Employees
1,534
Year Founded
1994

Profitability

Net Income
$76.46 million
Pretax Margin
4.98%

Debt

Sales & Book Value

Annual Sales
$1.54 billion
Cash Flow
$4.21 per share
Book Value
$43.08 per share

Miscellaneous

Free Float
26,501,000
Market Cap
$1.10 billion
Optionable
Optionable
Beta
1.45

Social Links

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

COWN Stock Analysis - Frequently Asked Questions

How were Cowen's earnings last quarter?

Cowen Inc. (NASDAQ:COWN) issued its quarterly earnings data on Thursday, October, 28th. The financial services provider reported $1.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.22 by $0.10. The financial services provider had revenue of $359.06 million for the quarter, compared to analyst estimates of $336.73 million. Cowen had a net margin of 4.97% and a trailing twelve-month return on equity of 7.05%. During the same period in the previous year, the firm earned $1.25 EPS.

Is Cowen a good dividend stock?

Cowen (NASDAQ:COWN) pays an annual dividend of $0.48 per share and currently has a dividend yield of 1.23%. The dividend payout ratio is 21.92%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for COWN.

When did Cowen's stock split?

Shares of Cowen reverse split before market open on Monday, December 5th 2016. The 1-4 reverse split was announced on Wednesday, November 9th 2016. The number of shares owned by shareholders was adjusted after the market closes on Friday, December 2nd 2016. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

What is Jeffrey Solomon's approval rating as Cowen's CEO?

16 employees have rated Cowen Chief Executive Officer Jeffrey Solomon on Glassdoor.com. Jeffrey Solomon has an approval rating of 100% among the company's employees. This puts Jeffrey Solomon in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Cowen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cowen investors own include Crown Castle (CCI), OPKO Health (OPK), Advanced Micro Devices (AMD), Abbott Laboratories (ABT), Corbus Pharmaceuticals (CRBP), RTX (RTX), AbbVie (ABBV), KushCo (KSHB).

This page (NASDAQ:COWN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners